Navigation Links
Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements
Date:3/27/2008

BERKELEY HEIGHTS, N.J., March 27 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced that the NASDAQ Listing Qualifications Panel has granted the Company's request for an extension of time to achieve full compliance with the applicable NASDAQ listing requirements. Pursuant to the Panel's decision, the listing of the Company's common stock will be transferred from The NASDAQ Global Market to The NASDAQ Capital Market, effective with the open of trading on Friday, March 28, 2008. The Company will continue to trade under its existing symbol, GNTA.

As disclosed on November 16, 2007 and January 11, 2008, the Company was previously notified by NASDAQ that it no longer satisfied the stockholders' equity requirement for continued listing on The NASDAQ Global Market, as set forth in Marketplace Rule 4350(a)(3). In response, the Company appeared before the Panel at a hearing on February 21, 2008.

The Company's continued listing on The NASDAQ Capital Market is subject to the Company's compliance with certain conditions, including evidence of the Company's ability to sustain compliance with the $2.5 million stockholders' equity requirement, as set forth in Marketplace Rule 4310(c)(3), and the submission of the required transfer application to NASDAQ within the next seven days. The Company currently expects to be able to comply with the Panel's conditions for continued listing on The NASDAQ Capital Market; however, there can be no assurance that the Company will be able to achieve or sustain such compliance.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Auditors for Genta Incorporated Express Going Concern Qualification
2. Genta Announces Senior Management Changes
3. Genta Announces Common Stock Offering of Approximately $3.1 Million
4. Genta Incorporated to Present at the BIO CEO & Investor Conference
5. Genta Receives Notice of Non-Compliance With NASDAQ Rule
6. Genta Receives NASDAQ Non-Compliance Notice
7. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
8. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
9. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
10. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
11. Syngenta Licenses Chromatin Gene Stacking Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... discovery by scientists at the University of East Anglia ... use domestic or agricultural waste to generate clean electricity. ... Proceedings of the National Academy of Sciences (PNAS), ... mechanism by which some bacteria survive by ,breathing rocks,. ... the development of new microbe-based technologies such as fuel ...
(Date:12/16/2009)... cause of death from roadside bombs to freeway crashes. ... age 4 to 44, often overwhelms the body,s natural ... natural process, a team led by Erin Lavik, a ... her former doctoral student, James P. Bertram, built synthetic ... bleeding., Their work is published in Science Translational ...
(Date:12/16/2009)... Biosciences Corporation (Nasdaq: MATK ) today announced its ... ended October 31, 2009. Revenues for the fourth quarter ... the fourth quarter of fiscal 2008. Net income was ... fourth quarter of fiscal 2009, a 5% increase compared ... last year,s fourth quarter. The fourth quarter of ...
(Date:12/16/2009)... the Best in the Nation ,, PHILADELPHIA, ... announces it has been granted Magnet(R) recognition by ... Program(R). Magnet(R) is one of the highest levels ... achieve, and places Hahnemann among the five percent ... this prestigious distinction. ,, At 9:00 am on ...
Breaking Biology Technology:'Rock-breathing' bacteria could generate electricity and clean up oil spills 2Researchers take the inside route to halt bleeding 2Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3
... data on the PROMUS(TM) Stent, NATICK, Mass., ... ) today announced that the first patient has ... European,registry. The registry is the first to observe ... outcome data for Boston,Scientific,s PROMUS(TM) Everolimus-Eluting Coronary Stent ...
... - New Agreement Provides for Development and Promotion of OraQuick(R) ... ... BETHLEHEM, Pa., Feb. 11 Schering-,Plough Corporation (NYSE: SGP ... to collaborate on the development and,promotion of a rapid oral ...
... Chakshu Research, a,specialty pharmaceutical company targeted at ... ocular diseases, announced,the addition of Dr. Randall J. ... of 2007., (Logo: http://www.newscom.com/cgi-bin/prnh/20080211/AQM073ALOGO ), ... A. Moran Eye Center and serves as the,Chairman ...
Other Biology Technology:Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 2Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 3Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents 4Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test 2Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test 3Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test 4Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test 5Chakshu Research Announces Appointment of Dr. Randall Olson as Director 2
(Date:12/16/2009)... of Energy Steven Chu announced today the winners of ... in research and development supporting the Department of Energy ... will receive a gold medal, a citation and $50,000. ... in Washington, DC early next year., "The contributions made ... energy security of the United States are wide-ranging and ...
(Date:12/16/2009)... cells, molecules form an intricate network of interactions. ... measure individual molecular reactions outside the cells. Since ... in the laboratory, scientists suspect that the kinetics ... from external probes. We expected the cellular reaction ... Dieter Braun. "However, our novel optical approach showed ...
(Date:12/16/2009)... planet for more than 4 billion years before humans ... many eons more. That suggests they may have something ... University bacteria expert Prof. Eshel Ben-Jacob of the Raymond ... in the study of bacteria, presents compelling evidence to ... should not automatically opt for the swine flu H1N1 ...
Breaking Biology News(10 mins):Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2Looking for the heartbeat of cellular networks 2Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3Scientists explain how death receptors designed to kill our cells may make them stronger 8674 1Scientists explain how death receptors designed to kill our cells may make them stronger 8674 2Vaccine shows therapeutic promise against advanced melanoma 47471 1Vaccine shows therapeutic promise against advanced melanoma 47471 2Vaccine shows therapeutic promise against advanced melanoma 47471 3Is your environment damaging your health 3F New center aims to find out 47466 1Is your environment damaging your health 3F New center aims to find out 47466 2Is your environment damaging your health 3F New center aims to find out 47466 3
... how best to manage some of Florida,s most popular ... has published Effective Strategies for the Management of Sustainable ... Bonefish Fisheries. , Ault, an assistant professor in the ... bonefish census, has a unique high-tech tagging approach to ...
... scientists, mathematicians, and biologists from around the world have ... genetic ancestry of thousands of individuals in minutes, without ... will be published in the September 2007 edition of ... of its kind that require prior knowledge of an ...
... Pennsylvania School of Veterinary Medicine have demonstrated the potential ... animals. The method employs a harmless gene therapy ... cells, which is then passed naturally on to offspring. ... Center for Animal Transgenesis and Germ Cell Research at ...
Other Biology News:New tarpon, bonefish compendium published 2Computer program traces ancestry using anonymous DNA samples 2Penn Veterinary Medicine report new strategy to create genetically-modified animals 2
Synaptotagmin, phosphoSer309...
... Immunogen: ... region encompassing the human, mouse, ... Accession Number: ... Assurance: Routinely evaluated by ...
Goat polyclonal to PPP2R5D Immunogen: Peptide with sequence KRAEEFLTASQEAL, from C Terminus of the protein sequence according to NP_006236...
...
Biology Products: